NCT04016480View on ClinicalTrials.gov

HFNC During Bronchoscopy for Bronchoalveolar Lavage

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Acute Respiratory FailureBronchoscopyBronchoalveolar Lavage
Interventions
DEVICE

High Flow Nasal Cannula

High Flow Nasal Cannula will be set at 60 liters per minute of air/oxygen admixture to reach a peripheral oxygen saturation equal or greater than 94%

DEVICE

Conventional Oxygen Therapy

Conventional Oxygen Therapy will be administered through nasal cannula with a oxygen flow set to achieve a peripheral oxygen saturation equal or greater than 94%

Trial Locations (1)

Unknown

AOU Mater Domini, Catanzaro

All Listed Sponsors
lead

University Magna Graecia

OTHER

NCT04016480 - HFNC During Bronchoscopy for Bronchoalveolar Lavage | Biotech Hunter | Biotech Hunter